Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study

[1]  Wanqing Chen,et al.  Nasopharyngeal carcinoma incidence and mortality in China, 2013 , 2013, Chinese journal of cancer.

[2]  S. Kondo,et al.  Progress and controversy for the role of chemotherapy in nasopharyngeal carcinoma. , 2015, Japanese journal of clinical oncology.

[3]  Wanqing Chen,et al.  Nasopharyngeal carcinoma incidence and mortality in China in 2010 , 2014, Chinese journal of cancer.

[4]  Rensheng Wang,et al.  Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  Yachao Li,et al.  Concurrent chemoradiotherapy followed by adjuvant chemotherapy compared with concurrent chemoradiotherapy alone for the treatment of locally advanced nasopharyngeal carcinoma: a retrospective controlled study. , 2014, Current oncology.

[6]  Chong Zhao,et al.  Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  H. Ying,et al.  A phase III randomized study comparing neoadjuvant chemotherapy with concurrent chemotherapy combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma: updated long-term survival outcomes. , 2014, Oral oncology.

[8]  K. Ang,et al.  Head and Neck Cancers, Version 2.2013 , 2013 .

[9]  Y. Mao,et al.  Significant efficacies of neoadjuvant and adjuvant chemotherapy for nasopharyngeal carcinoma by meta-analysis of published literature-based randomized, controlled trials. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  Ying Sun,et al.  Progress report of a randomized trial comparing long‐term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China , 2013, Cancer.

[11]  Xuemei Ji,et al.  Survival Benefit of Adding Chemotherapy to Intensity Modulated Radiation in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma , 2013, PloS one.

[12]  J. Shah,et al.  Head and Neck Cancers , Version 1 . 2015 Featured Updates to the NCCN Guidelines , 2015 .

[13]  S. Zhang,et al.  A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  Rensheng Wang,et al.  Definitive intensity-modulated radiation therapy for nasopharyngeal carcinoma: long-term outcome of a multicenter prospective study , 2012, Journal of Cancer Research and Clinical Oncology.

[15]  Ying Huang,et al.  Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy , 2011, Chinese journal of cancer.

[16]  Li-Zhi Liu,et al.  INTENSITY-MODULATED RADIOTHERAPY VERSUS CONVENTIONAL TWO-DIMENSIONAL RADIOTHERAPY INFLUENCE THE TREATMENT RESULTS IN NASOPHARYNGEAL CARCINOMA PATIENTS ? , 2011 .

[17]  B. O'Sullivan,et al.  A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  B. O'Sullivan,et al.  Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma. , 2010, Journal of the National Cancer Institute.

[19]  C. Qian,et al.  Is nasopharyngeal cancer really a "Cantonese cancer"? , 2010, Chinese journal of cancer.

[20]  Jianji Pan,et al.  Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: Experience of 370 consecutive cases , 2010, BMC Cancer.

[21]  豊 木村,et al.  胃癌手術におけるCommon Terminology Criteria for Adverse Events v3.0を利用した合併症の評価 , 2009 .

[22]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[23]  D. Machin,et al.  Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  A. Chan,et al.  Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma , 2005, Cancer.

[25]  Jun Ma,et al.  Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: A pooled data analysis of two phase III trials. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J. Sham,et al.  Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Chong Zhao,et al.  [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma]. , 2004, Ai zheng = Aizheng = Chinese journal of cancer.

[28]  T. Mok,et al.  Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Jun Ma,et al.  Is the 1997 AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations? , 2001, International journal of radiation oncology, biology, physics.

[30]  S. H. Cheng,et al.  Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy. , 2000, International journal of radiation oncology, biology, physics.

[31]  M. Leblanc,et al.  Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  J. Overgaard,et al.  Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[33]  V. Atichartakarn,et al.  Treatment of nasopharyngeal carcinoma. , 1992, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[34]  Pelayo Vilar,et al.  Nasopharyngeal Carcinoma , 1966 .